Biotech headwinds are driving double-digit revenue growth and profitability for these two mid-caps.

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

Shares of West Pharmaceutical Services Inc. shed 4.49% to $236.66 Friday, on what proved to be an all-around mixed trading ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2026, according to Statista. The oncology segment alone is expected to generate $232 billion in sales this year.

And, if all goes well, over the next five years as well.

Corvus Pharmaceuticals, Inc. jumps 165% on Phase 1 soquelitinib atopic dermatitis data; learn key efficacy, funding, and ...

We recently published 10 Stocks With Effortless Double-, Triple-Digit Gains. Corvus Pharmaceuticals Inc. (NASDAQ:CRVS) was ...

Vertex Pharmaceutical (VRTX) stock gains as RBC Capital Markets upgrades the company to Outperform, citing a durable cystic ...

Ratings for Rhythm Pharmaceuticals (NASDAQ: RYTM) were provided by 13 analysts in the past three months, showcasing a mix of ...